m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer.

The anti-tumour antibody-dependent cell-mediated cytotoxicity (ADCC) capacity of the conventional antibody m17-1A was compared with its chimerised analogue c17-1A and a newer chimeric antibody, cSF25, specific for colonic adenocarcinoma. The results (AUC units +/- s.e.m., control versus cancer) show...

Descripción completa

Detalles Bibliográficos
Autores principales: Pullyblank, A. M., Guillou, P. J., Monson, J. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033396/
https://www.ncbi.nlm.nih.gov/pubmed/7917934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033396/
https://www.ncbi.nlm.nih.gov/pubmed/7917934

Ejemplares similares